Drugmakers will conduct lung-cancer trials under single protocol

06/12/2013 | Nature (free content)

A new project aims to create a "master protocol" that will involve multiple pharmaceutical companies using one experimental plan to test multiple lung-cancer treatments in hundreds of clinics throughout the US, speeding up the drug-approval process. The plan will match drugmakers with patients whose tumors are most genetically relevant to the tested treatments. "The drive is to make the whole process of personalized medicine more efficient," said Eric Rubin, vice president of oncology clinical research at Merck. If the project succeeds, it may be applied to additional cancers.

View Full Article in:

Nature (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI